Parasites often cause devastating diseases and represent a significant public health and
economic burden. More accurate and convenient diagnostic tools are needed in support of …

Background Cell-free DNA (cfDNA) sequencing has emerged as a novel laboratory method
for rapid and noninvasive diagnosis in prenatal screening, organ transplant rejection, and …

While tissue biopsy has for the longest time been the gold-standard in biomedicine,
precision/personalized medicine is making the shift toward liquid biopsies. Cell-free DNA …

Since its discovery in human blood plasma about 70 years ago, circulating cell-free DNA
(cfDNA) has become an attractive subject of research as noninvasive disease biomarker …

The study of cell-free DNA (cfDNA) is often challenging due to genomic DNA contamination,
low concentration, and high fragmentation. Therefore, it is important to optimize pre …

Circulating cell-free DNA (cfDNA) isolated from blood has been identified as a potential
biomarker in numerous fields, and has been the object of intensive research over the past …

Body fluids are constantly replenished with a population of genetically diverse cell-free DNA
(cfDNA) fragments, representing a vast reservoir of information reflecting real-time changes …

A liquid biopsy is a minimally invasive or non-invasive method to analyze a range of tumor
material in blood or other body fluids, including circulating tumor cells (CTCs), cell-free DNA …

Cell-free DNA (cfDNA) is easily accessible in peripheral blood and can be used as
biomarkers for cancer diagnostics, prognostics, and therapeutics. The applications of cfDNA …

The detection of circulating free DNA (cfDNA) has transformed the field of oncology and
prenatal diagnostics. Clinical application of cfDNA for disease diagnosis and monitoring …